DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

AI is rewriting biotech’s commercial playbook—cutting waste, shrinking teams, and giving first‑time drugmakers a faster, ...

The directory offers vital insights into 1,000 top global pharmaceutical and biotech companies, featuring key management, business activities, and more. It aids market research, strategic planning, ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

DUBLIN--(BUSINESS WIRE)--The "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...

E-Biotech® today formally announced the launch of its patent-pending artificial intelligence infrastructure platform for pharmaceutical and GMP compliance, following its public unveiling during a live ...

Article ‘Count’ and ‘Share’ for State Key Laboratory of Pharmaceutical Biotechnology, HKU based on listed parameters only. The articles listed below published by authors from State Key Laboratory of ...

As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on Wednesday decimated the stock market on Thursday. It had one of its worst ...

table { width: 100%; border-collapse: collapse; font-family: Arial, sans-serif; font-size: 14px; } th, td { padding: 8px; text-align: left; } th { background-color ...

During the first six months of this year, the pharmaceutical-biotech industry completed construction on a total of 31 new plants and research centers across North America During the first six months ...

Apogee Therapeutics (NASDAQ: APGE) is one of the 17 biotechnology stocks with more than 50% upside. On January 25, Citi analyst Geoff Meacham maintained a Buy rating on Apogee Therapeutics ...